The crucial role of GATA-1 in CCR3 gene transcription: Modulated balance by multiple GATA elements in the CCR3 regulatory region

Journal of Immunology

Volumn 185, Issue 11, 2010, Pages 6866-6875

  Kim, Byung Soo ^a   Uhm, Tae Gi ^a   Lee, Seol Kyoung ^b   Lee, Sin Hwa ^a   Kang, Jin Hyun ^a   Park, Choon Sik ^b   Chung, Il Yup ^a  

^a Hanyang University   (South Korea)

^b Soonchunhyang University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR3; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR GATA 1;

ARTICLE; BINDING AFFINITY; CANONICAL ANALYSIS; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; EOSINOPHIL; EXON; GEL MOBILITY SHIFT ASSAY; GENE INTERACTION; GENE REGULATORY NETWORK; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; INTRON; PLASMID; POINT MUTATION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; REPORTER GENE; TRANSACTIVATION;

BASE SEQUENCE; CELL LINE; CELL LINE, TUMOR; EXONS; EYE PROTEINS; GATA TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION; HUMANS; INTRONS; K562 CELLS; LIGANDS; MOLECULAR SEQUENCE DATA; POINT MUTATION; RECEPTORS, CCR3; REGULATORY SEQUENCES, NUCLEIC ACID; RESPONSE ELEMENTS; SEQUENCE DELETION; TRANSCRIPTION, GENETIC;

EID: 78650654759     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1001037     Document Type: Article

References (46)

1. Gleich, G. J. 1990. The eosinophil and bronchial asthma: current understanding. J. Allergy Clin. Immunol. 85:422-436.
2. Hamelmann, E., and E. W. Gelfand. 2001. IL-5-induced airway eosinophilia-the key to asthma? Immunol. Rev. 179:182-191.
3. Rothenberg, M. E., and S. P. Hogan. 2006. The eosinophil. Annu. Rev. Immunol. 24:147-174.
4. Rosenberg, H. F., S. Phipps, and P. S. Foster. 2007. Eosinophil trafficking in allergy and asthma. J. Allergy Clin. Immunol. 119:1303-1310.
5. Mould, A. W., K. I. Matthaei, I. G. Young, and P. S. Foster. 1997. Relationship between interleukin-5 and eotaxin in regulating blood and tissue eosinophilia in mice. J. Clin. Invest. 99:1064-1071.
6. Foster, P. S., A. W. Mould, M. Yang, J. Mackenzie, J. Mattes, S. P. Hogan, S. Mahalingam, A. N. Mckenzie, M. E. Rothenberg, I. G. Young, et al. 2001. Elemental signals regulating eosinophil accumulation in the lung. Immunol. Rev. 179:173-181.
7. Rothenberg, M. E., J. A. MacLean, E. Pearlman, A. D. Luster, and P. Leder. 1997. Targeted disruption of the chemokine eotaxin partially reduces antigeninduced tissue eosinophilia. J. Exp. Med. 185:785-790.
8. Humbles, A. A., B. Lu, D. S. Friend, S. Okinaga, J. Lora, A. Al-Garawi, T. R. Martin, N. P. Gerard, and C. Gerard. 2002. The murine CCR3 receptor regulates both the role of eosinophils and mast cells in allergen-induced airway inflammation and hyperresponsiveness. Proc. Natl. Acad. Sci. USA 99:1479-1484.
9. Ma, W., P. J. Bryce, A. A. Humbles, D. Laouini, A. Yalcindag, H. Alenius, D. S. Friend, H. C. Oettgen, C. Gerard, and R. S. Geha. 2002. CCR3 is essential for skin eosinophilia and airway hyperresponsiveness in a murine model of allergic skin inflammation. J. Clin. Invest. 109:621-628.
10. Pope, S. M., N. Zimmermann, K. F. Stringer, M. L. Karow, and M. E. Rothenberg. 2005. The eotaxin chemokines and CCR3 are fundamental regulators of allergeninduced pulmonary eosinophilia. J. Immunol. 175:5341-5350.
11. Justice, J. P., M. T. Borchers, J. R. Crosby, E. M. Hines, H. H. Shen, S. I. Ochkur, M. P. McGarry, N. A. Lee, and J. J. Lee. 2003. Ablation of eosinophils leads to a reduction of allergen-induced pulmonary pathology. Am. J. Physiol. Lung Cell. Mol. Physiol. 284: L169-L178.
12. Rådinger, M., A. K. Johansson, B. Sitkauskiene, M. Sjöstrand, and J. Lötvall. 2004. Eotaxin-2 regulates newly produced and CD34 airway eosinophils after allergen exposure. J. Allergy Clin. Immunol. 113:1109-1116.
13. Fryer, A. D., L. H. Stein, Z. Nie, D. E. Curtis, C. M. Evans, S. T. Hodgson, P. J. Jose, K. E. Belmonte, E. Fitch, and D. B. Jacoby. 2006. Neuronal eotaxin and the effects of CCR3 antagonist on airway hyperreactivity and M2 receptor dysfunction. J. Clin. Invest. 116:228-236.
14. Wegmann, M., R. Göggel, S. Sel, S. Sel, K. J. Erb, F. Kalkbrenner, H. Renz, and H. Garn. 2007. Effects of a low-molecular-weight CCR-3 antagonist on chronic experimental asthma. Am. J. Respir. Cell Mol. Biol. 36:61-67.
15. Mori, Y., H. Iwasaki, K. Kohno, G. Yoshimoto, Y. Kikushige, A. Okeda, N. Uike, H. Niiro, K. Takenaka, K. Nagafuji, et al. 2009. Identification of the human eosinophil lineage-committed progenitor: revision of phenotypic definition of the human common myeloid progenitor. J. Exp. Med. 206:183-193.
16. Vijh, S., D. E. Dayhoff, C. E. Wang, Z. Imam, P. K. Ehrenberg, and N. L. Michael. 2002. Transcription regulation of human chemokine receptor CCR3: evidence for a rare TATA-less promoter structure conserved between drosophila and humans. Genomics 80:86-95.
17. Zimmermann, N., B. L. Daugherty, J. L. Kavanaugh, F. Y. El-Awar, E. A. Moulton, and M. E. Rothenberg. 2000. Analysis of the CC chemokine receptor 3 gene reveals a complex 59 exon organization, a functional role for untranslated exon 1, and a broadly active promoter with eosinophil-selective elements. Blood 96:2346-2354.
18. Scotet, E., S. Schroeder, and A. Lanzavecchia. 2001. Molecular regulation of CC-chemokine receptor 3 expression in human T helper 2 cells. Blood 98:2568-2570.
19. Zimmermann, N., J. L. Colyer, L. E. Koch, and M. E. Rothenberg. 2005. Analysis of the CCR3 promoter reveals a regulatory region in exon 1 that binds GATA-1. BMC Immunol. 6:7.
20. Yu, C., A. B. Cantor, H. Yang, C. Browne, R. A. Wells, Y. Fujiwara, and S. H. Orkin. 2002. Targeted deletion of a high-affinity GATA-binding site in the GATA-1 promoter leads to selective loss of the eosinophil lineage in vivo. J. Exp. Med. 195:1387-1395.
21. Hirasawa, R., R. Shimizu, S. Takahashi, M. Osawa, S. Takayanagi, Y. Kato, M. Onodera, N. Minegishi, M. Yamamoto, K. Fukao, et al. 2002. Essential and instructive roles of GATA factors in eosinophil development. J. Exp. Med. 195:1379-1386.
22. Kulessa, H., J. Frampton, and T. Graf. 1995. GATA-1 reprograms avian myelomonocytic cell lines into eosinophils, thromboblasts, and erythroblasts. Genes Dev. 9:1250-1262.
23. McNagny, K. M., M. H. Sieweke, G. Döderlein, T. Graf, and C. Nerlov. 1998. Regulation of eosinophil-specific gene expression by a C/EBP-Ets complex and GATA-1. EMBO J. 17:3669-3680.
24. Zon, L. I., Y. Yamaguchi, K. Yee, E. A. Albee, A. Kimura, J. C. Bennett, S. H. Orkin, and S. J. Ackerman. 1993. Expression of mRNA for the GATA-binding proteins in human eosinophils and basophils: potential role in gene transcription. Blood 81:3234-3241.
25. Iwasaki, H., S. Mizuno, R. Mayfield, H. Shigematsu, Y. Arinobu, B. Seed, M. F. Gurish, K. Takatsu, and K. Akashi. 2005. Identification of eosinophil lineage-committed progenitors in the murine bone marrow. J. Exp. Med. 201:1891-1897.
26. Yamaguchi, Y., S. J. Ackerman, N. Minegishi, M. Takiguchi, M. Yamamoto, and T. Suda. 1998. Mechanisms of transcription in eosinophils: GATA-1, but not GATA-2, transactivates the promoter of the eosinophil granule major basic protein gene. Blood 91:3447-3458.
27. Dyer, K. D., and H. F. Rosenberg. 2000. Shared features of transcription: mutational analysis of the eosinophil/basophil Charcot-Leyden crystal protein gene promoter. J. Leukoc. Biol. 67:691-698.
28. Qiu, Z., K. D. Dyer, Z. Xie, M. Rådinger, and H. F. Rosenberg. 2009. GATA transcription factors regulate the expression of the human eosinophil-derived neurotoxin (RNase 2) gene. J. Biol. Chem. 284:13099-13109.
29. Martin, D. I., and S. H. Orkin. 1990. Transcriptional activation and DNA binding by the erythroid factor GF-1/NF-E1/Eryf 1. Genes Dev. 4:1886-1898.
30. Omichinski, J. G., C. Trainor, T. Evans, A. M. Gronenborn, G. M. Clore, and G. Felsenfeld. 1993. A small single-"finger" peptide from the erythroid transcription factor GATA-1 binds specifically to DNA as a zinc or iron complex. Proc. Natl. Acad. Sci. USA 90:1676-1680.
31. Ferreira, R., K. Ohneda, M. Yamamoto, and S. Philipsen. 2005. GATA1 function, a paradigm for transcription factors in hematopoiesis. Mol. Cell. Biol. 25:1215-1227.
32. Trainor, C. D., J. G. Omichinski, T. L. Vandergon, A. M. Gronenborn, G. M. Clore, and G. Felsenfeld. 1996. A palindromic regulatory site within vertebrate GATA-1 promoters requires both zinc fingers of the GATA-1 DNA-binding domain for high-affinity interaction. Mol. Cell. Biol. 16:2238-2247.
33. Trainor, C. D., R. Ghirlando, and M. A. Simpson. 2000. GATA zinc finger interactions modulate DNA binding and transactivation. J. Biol. Chem. 275:28157-28166.
34. Kang, J. H., D. H. Lee, J. S. Lee, H. J. Kim, J. W. Shin, Y. H. Lee, Y. S. Lee, C. S. Park, and I. Y. Chung. 2005. Eosinophilic differentiation is promoted by blockage of Notch signaling with a gamma-secretase inhibitor. Eur. J. Immunol. 35:2982-2990.
35. McNagny, K., and T. Graf. 2002. Making eosinophils through subtle shifts in transcription factor expression. J. Exp. Med. 195: F43-F47.
36. Abonyo, B. O., M. S. Alexander, and A. S. Heiman. 2005. Autoregulation of CCL26 synthesis and secretion in A549 cells: a possible mechanism by which alveolar epithelial cells modulate airway inflammation. Am. J. Physiol. Lung Cell. Mol. Physiol. 289: L478-L488.
37. Cui, C. H., T. Adachi, H. Oyamada, Y. Kamada, T. Kuwasaki, Y. Yamada, N. Saito, H. Kayaba, and J. Chihara. 2002. The role of mitogen-activated protein kinases in eotaxin-induced cytokine production from bronchial epithelial cells. Am. J. Respir. Cell Mol. Biol. 27:329-335.
38. Richter, M., A. M. Cantin, C. Beaulieu, A. Cloutier, and P. Larivée. 2003. Zinc chelators inhibit eotaxin, RANTES, and MCP-1 production in stimulated human airway epithelium and fibroblasts. Am. J. Physiol. Lung Cell. Mol. Physiol. 285: L719-L729.
39. Du, J., M. J. Stankiewicz, Y. Liu, Q. Xi, J. E. Schmitz, J. A. Lekstrom-Himes, and S. J. Ackerman. 2002. Novel combinatorial interactions of GATA-1, PU.1, and C/EBPepsilon isoforms regulate transcription of the gene encoding eosinophil granule major basic protein. J. Biol. Chem. 277:43481-43494.
40. Yang, D., S. Suzuki, L. J. Hao, Y. Fujii, A. Yamauchi, M. Yamamoto, M. Nakamura, and A. Kumatori. 2000. Eosinophil-specific regulation of gp91 (phox) gene expression by transcription factors GATA-1 and GATA-2. J. Biol. Chem. 275:9425-9432.
41. Ghirlando, R., and C. D. Trainor. 2000. GATA-1 bends DNA in a siteindependent fashion. J. Biol. Chem. 275:28152-28156.
42. Weber, M., I. Hellmann, M. B. Stadler, L. Ramos, S. Pääbo, M. Rebhan, and D. Schübeler. 2007. Distribution, silencing potential and evolutionary impact of promoter DNA methylation in the human genome. Nat. Genet. 39:457-466.
43. Comb, M., and H. M. Goodman. 1990. CpG methylation inhibits proenkephalin gene expression and binding of the transcription factor AP-2. Nucleic Acids Res. 18:3975-3982.
44. Agalioti, T., G. Chen, and D. Thanos. 2002. Deciphering the transcriptional histone acetylation code for a human gene. Cell 111:381-392.
45. Witt, O., K. Sand, and A. Pekrun. 2000. Butyrate-induced erythroid differentiation of human K562 leukemia cells involves inhibition of ERK and activation of p38 MAP kinase pathways. Blood 95:2391-2396.
46. Adachi, T., B. K. Choudhury, S. Stafford, S. Sur, and R. Alam. 2000. The differential role of extracellular signal-regulated kinases and p38 mitogen-activated protein kinase in eosinophil functions. J. Immunol. 165:2198-2204.